Skip to main content
Daniel Moreno De Luca, MD, Psychiatry, East Providence, RI, Rhode Island Hospital

DanielMoreno De LucaMDMSc

Psychiatry East Providence, RI

Child & Adolescent Psychiatry

CASA Research Chair; Associate Professor and Principal Investigator at Precision Medicine in Autism (PRISMA) Group, University of Alberta; Attending Child, Adolescent, and Adult Psychiatrist, Alberta Health Services

Dr. Moreno De Luca is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moreno De Luca's full profile

Already have an account?

Summary

  • In my path to becoming a physician-scientist, I have been deeply interested on the impact of genetic variation on brain disorders, and how to use discoveries in the field to enhance patient care. I have pursued clinical training in child, adolescent, and adult psychiatry, and research training in genetics and neuroscience, which has given me a unique perspective to blend insights from these diverse but complementary fields.

    My research has focused on the genetic underpinnings of autism and other neuropsychiatric conditions, specifically on the role of rare genetic variants as risk factors for developmental brain disorders. Together with my collaborators, we identified the 17q12 deletion as a risk factor for autism and schizophrenia by pulling together genetic data from over 70,000 people worldwide, and we have expanded our work on this and other rare genetic variants. This work has propelled my drive to focus the next stage of my career in developing the scientific support and infrastructure required to bring research discoveries to clinical practice with a focus on genomically-informed interventions and precision medicine.

    Throughout this path, I have had the opportunity to work closely with trainees at different levels, including psychiatry residents and child and adolescent psychiatry fellows who I supervise as they deliver healthcare in our genomic psychiatry consultation service, the clinical arm of our research efforts, and who are now starting their path into academic clinical medicine.

    Most importantly, I work closely and jointly with the community of people with rare genetic changes and those on the autism spectrum or developmental disorders to ensure that their voices and insights are front and center, keeping our efforts grounded. Together, we achieve this by a strong focus on outreach and media strategies that can share our research discoveries, our clinical efforts, and our educational opportunities in a clear, accesible way in several languages.

Education & Training

  • Harvard Medical School
    Harvard Medical SchoolBioethics, 2021 - 2022
  • Brown University
    Brown UniversityFellowship, Child and Adolescent Psychiatry, 2016 - 2018
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Psychiatry, 2012 - 2016
  • Emory University School of Medicine
    Emory University School of MedicinePost-Doctoral Fellowship, Neurogenetics, 2008 - 2012
  • Université Pierre et Marie Curie - Paris 6, Sorbonne Universités
    Université Pierre et Marie Curie - Paris 6, Sorbonne UniversitésMSc, Neuroscience, Mention Bien (Magna Cum Laude), 2007 - 2008
  • Industrial University of Santander Faculty of Medicine
    Industrial University of Santander Faculty of MedicineClass of 2005

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2018 - 2024
  • CT State Medical License
    CT State Medical License 2014 - 2018
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Publications & Presentations

PubMed

Professional Memberships

Other Languages

  • Spanish, French, Italian

Hospital Affiliations